BLRX

BioLineRx Share Price

3.43
0.14 (4.26%)
3.43
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
BioLineRx Ltd BLRX NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.14 4.26% 3.43 19:22:25
Open Price Low Price High Price Close Price Prev Close
3.26 3.22 3.34 3.28 3.29
Bid Price Ask Price Spread News
3.33 3.40 0.07 - -
Trades Volume VWAP Dollar Volume Avg Volume
1,696 551,877  3.27  1,804,708 -
Last Trade Time Type Quantity Stock Price Currency
19:18:49 3  3.42 USD

Period:

Draw Mode:

BioLineRx Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 162.15M 47.27M 47.27M  -  - -1.95 -1.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - - - -

more financials information »

News BioLineRx

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

BLRX Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

BioLine Rx Ltd is a clinical-stage biopharmaceutical development company with a strategic focus on oncology. Its development and commercialization pipeline consists of two clinical-stage therapeutic candidates - Motixafortide, a novel peptide for the treatment of solid tumors, hematological malignancies and stem cell mobilization, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, it has an off- strategy, a legacy therapeutic product called BL-5010 for the treatment of skin lesions.


Your Recent History
NASDAQ
BLRX
BioLineRx
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.